Wilson Therapeutics Announces the Appointment of Dr. Carl Bjartmar as Chief Medical Officer

STOCKHOLM, July 22, 2015 -- (Healthcare Sales & Marketing Network) -- Wilson Therapeutics AB, a privately-held biopharmaceutical company developing novel treatments for patients with Wilson's Disease, today announced the appointment of Dr. Carl Bjartmar a... Biopharmaceuticals, PersonnelWilson Therapeutics, Wilson's Disease
Source: HSMN NewsFeed - Category: Pharmaceuticals Source Type: news